C4E (Cannabis 4 Epilepsy)

C4E (Cannabis 4 Epilepsy) is a non-profit initiative that provides support, education and assistance on the use of medical cannabis for epilepsy. C4E provides support to Australians who do not respond to conventional antiepileptic drugs (AEDs). 

A range of medical cannabis factsheets are published by the organisation, as well as lectures and events to providing education information. The organisation also assists patients in applying for access to medical cannabis through the Special Access Scheme (SAS). 

C4E regularly publishes the stories of Australians who treat their epilepsy with medical cannabis, as part of an initiative to break the stigma around the use of cannabis medicines. 

C4E is produced by Epilepsy Action Australia, a charity dedicated to supporting Australians with Epilepsy. C4E is also supported by the NIB Foundation and cannabis pharmaceutical companies MGC Pharma, Tilray, Satipharm and Medipharm.